Get the Stockscreener App
4.20
2.89%
-0.125
22nd Century Group, Inc. stock is traded at $4.20, with a volume of 3,951.
It is down -2.89% in the last 24 hours and down -3.00% over the past month.
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
See More
Previous Close:
$4.325
Open:
$4.34
24h Volume:
3,951
Relative Volume:
0.18
Market Cap:
$1.44M
Revenue:
$15.74M
Net Income/Loss:
$-12.86M
P/E Ratio:
-0.000909
EPS:
-4622.6032
Net Cash Flow:
$-8.71M
1W Performance:
-3.45%
1M Performance:
-3.00%
6M Performance:
-96.37%
1Y Performance:
-99.40%
1-Day Range:
$4.0923
$4.34
1-Week Range:
$3.73
$4.565
52-Week Range:
$3.61
$735.00
22nd Century Group, Inc. Stock (XXII) Company Profile
Name
22nd Century Group, Inc.
Sector
Industry
Phone
716-270-1523
Address
8560 Main Street, Williamsville, NY
Compare XXII vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
4.1603 | 1.49M | 15.74M | -12.86M | -8.71M | -4,622.60 |
VRTX
Vertex Pharmaceuticals Inc
|
515.67 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.59 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
993.07 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
215.47 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.63 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-22 | Initiated | Alliance Global Partners | Buy |
| Jun-15-22 | Initiated | Craig Hallum | Buy |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Jul-23-21 | Initiated | Cowen | Outperform |
| Oct-16-17 | Reiterated | Chardan Capital Markets | Buy |
| Aug-11-16 | Reiterated | Chardan Capital Markets | Buy |
View All
22nd Century Group, Inc. Stock (XXII) Latest News
22nd Century Group, Inc. 2Q 2026: Revenue $2.86M, EPS ($104) — 10-Q Summary - TradingView
22nd Century Group (XXII) gains 6.7% shareholder position from Anson-related funds - Stock Titan
Form 8K 22nd Century Group Inc For: 14 August By Investing.com - Investing.com India
22nd Century to Present at the Emerging Growth Conference on February 19, 2025 - kalkine.ca
22nd Century Group Inc (NASDAQ: XXII) Share Price, XXII Stock News, XXII Share Price & Updates - kalkine.ca
22nd Century Group Inc (XXII) (Q2 2026) Earnings Call Highlights - GuruFocus
XXII Q2 FY2026 earnings call - finance.biggo.com
22nd Century Group Inc (XXII) (Q2 2026) Earnings Call Highlights: Strategic Shift Toward ... - Yahoo Finance
Earnings call transcript: 22nd Century Group posts steep Q2 2026 miss - Investing.com
22nd Century Group Releases Q2 2026 Financial Results - AlphaStreet
Transcript : 22nd Century Group, Inc., Q2 2026 Earnings Call, Aug 13, 2026 - marketscreener.com
Q2 2026 22nd Century Group Inc Earnings Call Transcript - GuruFocus
22nd Century Group Q2 EPS misses estimate, sales miss consensus - scanx.trade
22nd Century Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Form 8K 22nd Century Group Inc For: 13 August By Investing.com - Investing.com Nigeria
XXII: Net revenues fell 29.9% year-over-year as focus shifted to higher-margin VLN® products - TradingView
22nd Century Group Reports Second Quarter 2026 Financial Results - The Manila Times
22nd Century: Q2 Earnings Snapshot - marketscreener.com
22nd Century Group reports Q2 2026 revenue $2.9M, net loss $3.3M, Adjusted EBITDA loss $3.5M - TradingView
22nd Century Group Reports Q2 2026 Results and Expands VLN Retail Distribution - Quiver Quantitative
22nd Century Reports $2.9 Million Second-Quarter Revenue as VLN Distribution Expands - Quiver Quantitative
22nd Century Group, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
22nd Century Targets ~5,000 Stores for Low-Nicotine Cigarettes by Year-End 2026 - Stock Titan
Q4 2025 22nd Century Group Inc Earnings Call Transcript - GuruFocus
XXII Q2'26 Earnings: EPS estimate is (6.00) USD - TradingView
Form 8K 22nd Century Group Inc For: 11 August By Investing.com - Investing.com India
22nd Century Group Inc expected to post a loss of $18.00 a shareEarnings Preview - TradingView
XXII News | 22ND CENTURY GROUP INC (NASDAQ:XXII) - ChartMill
22ND CENTURY GROUP INC (XXII) Stock Chart - ChartMill
22nd Century Group to Announce Second Quarter 2026 Results on August 13, 2026 - The Manila Times
22nd Century Group to report Q2 results at 6 a.m. Aug. 13 - Stock Titan
22nd Century Group Inc (XXII) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
22nd Century Group Inc (XXII) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
22nd Century Group Inc (XXII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
22nd Century Group Inc (XXII) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
XXII|22nd Century Group Inc|Price:4.270|Chg%:-0.380 - TradingKey
Price to sales forward of 22nd Century Group, Inc – NASDAQ:XXII - TradingView
22nd Century Group Inc (XXII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
22nd Century Group, Inc Revenue Breakdown – BOATS:XXII - TradingView
Price to earnings forward of 22nd Century Group, Inc – BOATS:XXII - TradingView
22nd Century Tabs New Marketing VP - Tobacco Reporter
22nd Century Group appoints Katherine Rouse-Bailey as VP of Marketing - Bitget
22nd Century Group (Nasdaq: XXII) Appoints Katherine Rouse-Bailey as Vice President of Marketing - The Manila Times
VLN Cigarettes Carry FDA-Authorized “95% Less Nicotine” Claim - Stock Titan
Supplier Spotlights: 22nd Century Group, Diebold Nixdorf & Lay's - Convenience Store News
22nd Century Group Q1 2026 Earnings: Massive EPS Miss Amidst Strategic RestructuringEPS Growth Report - DonanımHaber
XXII Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
22nd Century Reportedly Losing Key Customer - Tobacco Reporter
Struggling 22nd Century Group set to lose key customer - Winston-Salem Journal
12 Consumer Staples Stocks Moving In Monday's Pre-Market Session - Benzinga
22nd Century Group, Inc. Stock (XXII) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.24%
1.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):